Evidence map›Paper›PMID 40468054›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

The role of matrix metalloproteinase expression levels in the pathogenesis of tympanosclerosis.

Semih Van, Doğukan Özdemir, Seda Koç Şahin, Şule Öztürk, Dursun Mehmet Mehel, Ayşe Çeçen

Abstract read
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Semih VanDepartment of Otolaryngology and Head & Neck Surgery Adıyaman Training and Research Hospital, Adıyaman, Turkey. semih.van1@gmail.com.ORCID http://orcid.org/0000-0001-6486-4500
Doğukan ÖzdemirDepartment of Otolaryngology and Head & Neck Surgery, Samsun University Samsun Training and Research Hospital, Samsun, Turkey.ORCID http://orcid.org/0000-0003-2008-163X
Seda Koç ŞahinDepartment of Medical Pathology, Samsun University Samsun Training and Research Hospital, Samsun, Turkey.ORCID http://orcid.org/0000-0003-0199-242X
Şule ÖztürkDepartment of Public Health, Samsun University Samsun Training and Research Hospital, Samsun, Turkey.ORCID http://orcid.org/0000-0002-0366-7455
Dursun Mehmet MehelDepartment of Otolaryngology and Head and Neck Surgery, Samsun Training and Research Hospital, Samsun, Turkey.ORCID http://orcid.org/0000-0002-5613-3393
Ayşe ÇeçenDepartment of Otolaryngology and Head & Neck Surgery, Samsun University Samsun Training and Research Hospital, Samsun, Turkey.ORCID http://orcid.org/0000-0001-6255-6125

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTympanosclerosis is a disease characterized by the accumulation of hyaline calcareous deposits in the tympanic membrane, tympanic cavity, ossicular chain, ligaments, and rarely, in the mastoid. Matrix metalloproteinases, which are involved in physiological and pathologic processes, are also likely to play a role in tympanosclerosis. In our study, we aimed to investigate the presence of MMP 2 and 9 in patients with chronic otitis media with tympanosclerosis and its possible effect on tympanosclerosis severity and prognosis.

methodsIn our study, 45 patients with myringosclerosis or myringosclerosis and intratympanic sclerosis who underwent endoscopic transcanal tympanoplasty due to COM (chronic otitis media) were included in the study group, and 35 patients with only COM, without tympanosclerosis, were included in the control group. Immunohistochemical staining of the mucosa samples of the eardrum and middle ear were compared with MMP-2 and MMP-9 in the study and control groups.

resultsThe rate of MMP-2 staining (64.3%) was higher than the control group (42.9%), and the rate of MMP-9 staining (16.7%) was lower than the control group (51.4%) (p < 0.05). The rate of MMP-9 staining in the middle ear mucosa samples (31.0%) was statistically lower than the control group (57.1%) (p < 0.05).

conclusionIn our study, high levels of MMP-2 staining in the study group and low levels of MMP-9 staining in the control group help to elucidate the complex relationship between both metalloproteinases. Compared with the inadequacy of animal models of tympanosclerosis to mimic the chronic process, our study reveals the late results of MMP-2 and MMP-9 in patients with tympanosclerosis.

Indexed as

Matrix Metalloproteinase 2Matrix Metalloproteinase 9MyringosclerosisOtitis MediaTympanic MembraneAdolescentAdultAgedCase-Control StudiesChronic DiseaseEar, MiddleFemaleHumansImmunohistochemistryMaleMiddle AgedMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP9 protein, humanMetalloproteinaseMMP-2MMP-9MyringosclerosisTympanosclerosis

Identifiers

PMID40468054
PMCPMC12605527

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.